# Novavax

Type: Company (NVAX)

Source: GetYourBrief — https://getyourbrief.com/entity/novavax
Canonical HTML page: https://getyourbrief.com/entity/novavax

## Recent coverage (5 stories, network-wide)

### Healthcare +2.9% to Record, S&P +0.21% as Yields Ease
2026-08-20 00:48:31 · Sector: finance · Sentiment: Strongly positive · Impact: 8/10 · Sources: 4

For finance readers, Aug. 19 was a case study in cross-asset relief: Treasury buyback news pulled the 30-year yield off its highest since 2007, feeding a 0.21% S&P 500 gain, while a more than 137% Moderna surge drove healthcare to a record 2.9% gain. The support for risk appetite masks a hawkish Fed minutes message and an unresolved long-term rate threat to AI-heavy valuations.
Full story: https://getfinancebrief.com/story/finance-markets-healthcare-record-yields-ease

### Moderna 177% Surge Lifts S&P 500 Healthcare Sector 2.9% to Record
2026-08-20 00:37:19 · Sector: health · Sentiment: Strongly positive · Impact: 8/10 · Sources: 4

Moderna's mRNA cancer therapy readout sent its shares up as much as 177%, driving a 2.9% record gain in the S&P 500 healthcare sector amid easing Treasury yields. The rally lifted peers including Merck, BioNTech and Novavax, but macro rate worries persist.
Full story: https://gethealthbrief.com/story/moderna-177-pct-healthcare-sector-record

### Novavax Cut to Sell by Wall Street Zen as Stock Trades at $7.41
2026-08-04 12:11:39 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78.
Full story: https://gethealthbrief.com/story/novavax-sell-downgrade-wall-street-zen-health

### Wall Street Zen Slaps Sell Ratings on CME, Novavax, and SNDL – 3 Stocks to Watch
2026-08-04 12:11:28 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Full story: https://getfinancebrief.com/story/wall-street-zen-downgrades-cme-nvax-sndl-finance

### Biotech Sell-Off: Novavax Downgraded to Sell Despite Revenue Beat
2026-08-04 12:11:16 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Novavax was slapped with a sell rating by Wall Street Zen, even after beating Q1 revenue estimates by 49%. The downgrade highlights biotech skepticism toward small-cap vaccine players in a shifting market.
Full story: https://getbiobrief.com/story/novavax-sell-downgrade-biotech-pharma

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.